PMID- 25951923 OWN - NLM STAT- MEDLINE DCOM- 20170201 LR - 20220330 IS - 1442-2050 (Electronic) IS - 1120-8694 (Linking) VI - 29 IP - 7 DP - 2016 Oct TI - Factors associated with nonresponse to proton pump inhibitors therapy in patients referred for esophageal pH-impedance monitoring. PG - 787-793 LID - 10.1111/dote.12374 [doi] AB - Nonresponse to proton pump inhibitors (PPI) concerns up to 40% of patients treated for gastroesophageal reflux disease (GERD). Identifying predictive factors of nonresponse might help to optimize patients' treatment. The aim of this study was to determine clinical factors associated with nonresponse to PPI therapy in patients referred for pH-impedance monitoring. One hundred and sixty-eight consecutive patients (105 females, mean age 52 years, range 17-83) were included between October 2011 and May 2013. Before the realization of high-resolution manometry and 24-hour pH-impedance monitoring they completed a questionnaire including Rome III criteria for functional dyspepsia and irritable bowel syndrome (IBS). Comparisons between patients with and without PPI response were performed using chi-square or analysis of variance tests. One hundred and twenty-six patients (83%) were considered as PPI nonresponders and 26 (17%) as responders. No significant difference was observed for age and body mass index. No manometric and pH-impedance profiles were identified as associated with PPI response. The percentage of patients with functional dyspepsia and IBS was higher in PPI nonresponders patients than in responders (65.6% and 27.2%, respectively, vs. 38.5% and 7.7%, P = 0.01 and P = 0.03). This study confirms that functional digestive disorders are more frequent in patients with persistent GERD symptoms on PPI and they might be indicative of nonresponse to PPI therapy. CI - (c) 2015 International Society for Diseases of the Esophagus. FAU - Garros, A AU - Garros A AD - Hospices Civils de Lyon, Digestive Physiology, Edouard Herriot Hospital, Lyon, France. FAU - Mion, F AU - Mion F AD - Hospices Civils de Lyon, Digestive Physiology, Edouard Herriot Hospital, Lyon, France. AD - Lyon I University, Lyon, France. AD - LabTAU, Lyon, France. FAU - Marjoux, S AU - Marjoux S AD - Hospices Civils de Lyon, Digestive Physiology, Edouard Herriot Hospital, Lyon, France. FAU - Damon, H AU - Damon H AD - Hospices Civils de Lyon, Digestive Physiology, Edouard Herriot Hospital, Lyon, France. FAU - Roman, S AU - Roman S AD - Hospices Civils de Lyon, Digestive Physiology, Edouard Herriot Hospital, Lyon, France. roman.sabine@gmail.com. AD - Lyon I University, Lyon, France. roman.sabine@gmail.com. AD - LabTAU, Lyon, France. roman.sabine@gmail.com. LA - eng PT - Journal Article DEP - 20150508 PL - United States TA - Dis Esophagus JT - Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus JID - 8809160 RN - 0 (Proton Pump Inhibitors) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Aged, 80 and over MH - Analysis of Variance MH - Chi-Square Distribution MH - *Drug Resistance MH - Dyspepsia/complications MH - *Esophageal pH Monitoring MH - Esophagus/*drug effects/physiopathology MH - Female MH - Gastroesophageal Reflux/complications/*drug therapy/physiopathology MH - Humans MH - Irritable Bowel Syndrome/complications MH - Male MH - Manometry MH - Middle Aged MH - Proton Pump Inhibitors/*pharmacology MH - Surveys and Questionnaires MH - Young Adult OTO - NOTNLM OT - PPI response OT - dyspepsia OT - gastroesophageal reflux disease OT - irritable bowel syndrome OT - pH-impedance monitoring EDAT- 2015/05/09 06:00 MHDA- 2017/02/02 06:00 CRDT- 2015/05/09 06:00 PHST- 2015/05/09 06:00 [pubmed] PHST- 2017/02/02 06:00 [medline] PHST- 2015/05/09 06:00 [entrez] AID - 10.1111/dote.12374 [doi] PST - ppublish SO - Dis Esophagus. 2016 Oct;29(7):787-793. doi: 10.1111/dote.12374. Epub 2015 May 8.